Navigation Links
Nuvasive Reports Third Quarter 2008 Financial Results

culates the non-GAAP financial measures provided in this earnings release excluding these costs and uses these non-GAAP financial measures to enable it to analyze further and more consistently the period-to-period financial performance of its core business operations. Management believes that providing investors with these non-GAAP measures gives them additional important information to enable them to assess, in the same way management assesses, the Company's current and future continuing operations. These non-GAAP measures are not in accordance with, or an alternative for, GAAP, and may be different from non-GAAP measures used by other companies. Set forth below are reconciliations of the non-GAAP financial measures to the comparable GAAP financial measure.

Reconciliation of Third Quarter 2008 Results

(in thousands, except per share amounts) $ Per Share

GAAP net loss per share (A) $(23,079) $(0.64)

In-process research and development (IPR&D) (C) 16,700 0.46

Other adjustments (E) 7,991 0.22

Earnings per share excluding IPR&D and other

adjustments 1,612 0.04

Stock-based compensation (B) 5,421 0.14

Amortization of acquired intangible assets (D) 931 0.03

Non-GAAP earnings per share (A) $7,964 $0.21

Shares used in computing GAAP net loss per

share (A) 35,931

Shares used in computing non-GAAP net loss per

share (A) 37,927

Reconciliation of Full Year 2008 Guidance

Range for Year Ending

(in thousands, except per share amounts) December 31, 2008'/>"/>

SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. NuVasive to Present at Morgan Stanley Global Healthcare Unplugged Conference
2. NuVasive Completes Acquisition of Osteocel Biologics Business
3. NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results
4. NuVasive to Present at William Blair 28th Annual Growth Stock Conference
5. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
6. NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference
7. NuVasive to Present at Canaccord Adams Small-Cap Orthopedics Conference
8. NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
9. NuVasive to Host Investor Reception on September 11, 2007
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
Post Your Comments:
(Date:10/9/2015)... SAN DIEGO , Oct. 9, 2015  DePuy ... ® Flex with Q-PACK ®  Technology**, the ... use in trauma-related extremity procedures (foot and ankle, hand ... The announcement was made here at the 2015 Orthopaedic ... (provides a natural scaffold for new bone growth) ...
(Date:10/8/2015)... WEST PALM BEACH, Fla. , Oct. 8, 2015 ... a leader in synthetic biology, today announced the appointment ... President, Head of Environment Sector, succeeding Nir Nimrodi ... Corporate Development.  Mr. Vaillancourt will direct Intrexon,s endeavors to ... North America , where he held ...
(Date:10/8/2015)... 8, 2015 Celemics, a global pioneer of ... North American market with the establishment of Celemics America, ... Europe , has secured itself in ... methodology and sample preparation for DNA sequencing and genetic ... and somatic genetic testing more accurately, quickly, and cost ...
(Date:10/8/2015)... 8, 2015  The ALS Association, in partnership with ... Challenge to revolutionize communication technology solutions for people living ... ALS (amyotrophic lateral sclerosis) is a progressive neurodegenerative ... and the spinal cord. Eventually, people with ALS lose ... often leads to total paralysis and death within two ...
Breaking Biology Technology:
... Epilepsy Drug to be Tested as Treatment for ... of a multi-site, Phase,II clinical trial to evaluate ... as a potential treatment for general anxiety,disorder., ... an,eight-week, double-blind, placebo-controlled, exploratory study being,conducted in 20 ...
... 31 Medarex, Inc.,(Nasdaq: MEDX ) today ... for,an undisclosed amount from its licensing partner, Novo ... submission of an Investigational New Drug,application by Novo ... by Medarex,s UltiMAb(R) technology. Medarex may receive future,milestone ...
... March 29 Boston,Scientific Corporation (NYSE: BSX ... data from more than 7,000 patients in the ... evaluate the safety performance of the,TAXUS(R) Express2(TM) Paclitaxel-Eluting ... Outcomes through two years in the simple-,use (single ...
Cached Biology Technology:
(Date:9/24/2015)... , Sept. 24, 2015  EyeLock LLC, a ... showcasing its award winning and latest technology in Booth ... Anaheim, California . EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:9/10/2015)... , Sept. 10, 2015 Report Details ... not quite delivered upon previous expectations of revenues, consumer ... the breakthrough year in which wearables begin to achieve ... One of the main reasons is the entrance of ... only the SmartWatches market, but the overall size of ...
(Date:9/8/2015)... 2015   TREW Marketing and ... Smart Marketing for Engineers TM : Content and Online ... insightful findings about engineers, preferences for online content marketing ... most value and trust, and where they look for ... audiences grapple with how to best implement online and ...
Breaking Biology News(10 mins):
... Coen, evolution expert Prof. Marcus Feldman, and aging specialists ... the winners of the 2011 Dan David Prize, which ... prizes are granted for "proven, exceptional and distinct excellence ... an outstanding contribution to humanity." The laureates, who ...
... An inexpensive and rapid testing method can effectively identify ... express a molecule associated with increased risk of disease ... Ping Yang from the Mayo Clinic, Rochester, USA, and ... in Thoracic Oncology (EMCTO), 24-26 February 2011, Lugano, Switzerland. ...
... amounts of high quality data on climate change and ... and climate models do not always have access to ... from the Department of Energy, the on-the-ground information will ... of Energy and the Environment. The DOE-funded project, ...
Cached Biology News:
Mouse monoclonal antibody to QARS - glutaminyl-tRNA synthetase...
Rabbit Anti-Mouse Ym1 Polyclonal Antibody,...
From formula-fed bovine calves Sterile, Cell culture tested...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
Biology Products: